<DOC>
	<DOCNO>NCT00516074</DOCNO>
	<brief_summary>This study explore effect exenatide ( give twice day ) versus placebo ( give twice day ) treatment change mean 24-hour heart rate 12 week period drug exposure patient type 2 diabetes .</brief_summary>
	<brief_title>A Study Assess Effect Exenatide Treatment Mean 24-Hour Heart Rate Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Diagnosed type 2 diabetes . Treated metformin and/or thiazolidinedione . HbA1c 6.5 % 9.5 % , inclusive . Body Mass Index ( BMI ) &gt; 25 kg/m^2 &lt; 40 kg/m^2 . Have previously receive exenatide glucagonlike peptide1 analog . Have participate interventional medical , surgical , pharmaceutical study ( study experimental , drug , medical , surgical treatment give ) within 30 day screen . This criterion include drug receive regulatory approval indication time study entry . Receiving beta blocker . Receiving treatment drug directly affect gastrointestinal motility , include limited Reglan® ( metoclopramide ) , Propulsid® ( cisapride ) , chronic macrolide antibiotic . Have receive treatment systemic glucocorticoid therapy oral , intravenous ( IV ) , intramuscular ( IM ) route within 6 week screen , regularly treat potent , inhale intranasal steroid know high rate systemic absorption bronchodilator . Have treat drug promote weight loss ( example , Adipex® [ phentermine ] , Acomplia® [ rimonabant ] , Xenical® [ orlistat ] , Meridia® [ sibutramine ] , Acutrim® [ phenylpropanolamine ] , similar overthecounter medication ) within 3 month screen . Have treat longer 2 week follow excluded medication within 3 month prior screen : *Insulin ; *Alphaglucosidase inhibitor ( example , Glyset® [ miglitol ] Precose® [ acarbose ] ) ; *Meglitinides ( example , Prandin® [ repaglinide ] Starlix® [ nateglinide ] ) ; *Sulfonylureas ( example , Glucotrol® [ glipizide ] Micronase® [ glyburide ] ) ; *Dipeptidyl peptidase IV ( DPPIV ) inhibitor ( example , Januvia™ [ sitagliptin ] ) Have donate blood within 60 day screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>exenatide</keyword>
	<keyword>Byetta</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>heart rate</keyword>
	<keyword>Amylin</keyword>
	<keyword>Lilly</keyword>
</DOC>